Spots Global Cancer Trial Database for perioperative chemotherapy
Every month we try and update this database with for perioperative chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study | NCT03150628 | Gastric Cancer Peritoneal Carc... HIPEC | Perioperative c... Cytoreduction HIPEC | 18 Years - | UMC Utrecht | |
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis | NCT02399410 | Colorectal Neop... | perioperative c... cytoreductive s... Intraperitoneal... | 18 Years - | University Hospital, Ghent | |
Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05970627 | Adenocarcinoma ... Adenocarcinoma ... Epstein-Barr Vi... | Toripalimab Oxaliplatin S1 | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
Perioperative Chemotherapy in Gastric Cancer | NCT04937738 | Gastric Cancer | Docetaxel Oxaliplatin Leucovorin Fluorouracil Capecitabine Oxaliplatin | 18 Years - 80 Years | Ukrainian Society of Clinical Oncology | |
Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG | NCT04878783 | Gastric Cancer Adenocarcinoma ... | CT scan | 18 Years - | University of Roma La Sapienza | |
Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | NCT03636893 | Gastric Cancer Chemotherapy Ef... | FLOT Chemothera... SOX Chemotherap... | 18 Years - 80 Years | Ruijin Hospital | |
Perioperative Chemotherapy in Gastric Cancer | NCT04937738 | Gastric Cancer | Docetaxel Oxaliplatin Leucovorin Fluorouracil Capecitabine Oxaliplatin | 18 Years - 80 Years | Ukrainian Society of Clinical Oncology | |
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer | NCT04999332 | Gastric Cancer Gastric Adenoca... Effects of Chem... Toxicity Due to... | leucovorin, oxa... | 20 Years - | National Cheng-Kung University Hospital | |
Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis | NCT02912052 | Colon Cancer | Peri-operative ... postoperative c... | 18 Years - 80 Years | The First Affiliated Hospital with Nanjing Medical University | |
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer | NCT01516944 | Gastric Cancer | Tegafur, Gimera... Tegafur, Gimera... Oxaliplatin; Ca... | 18 Years - 75 Years | Hebei Medical University | |
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer | NCT01516944 | Gastric Cancer | Tegafur, Gimera... Tegafur, Gimera... Oxaliplatin; Ca... | 18 Years - 75 Years | Hebei Medical University | |
Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer | NCT06028737 | Gastric Cancer Stomach Cancer GastroEsophagea... Gastric Adenoca... Gastroesophagea... Advanced Gastri... Gastric Neoplas... Stomach Neoplas... Gastrointestina... Advanced Gastro... Advanced Gastri... | Docetaxel Oxaliplatin Leucovorin Fluorouracil | 18 Years - 80 Years | Ukrainian Society of Clinical Oncology | |
Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer | NCT00865982 | Gastric Cancer Esophageal Canc... | Docetaxel, Cisp... | 18 Years - 75 Years | Charite University, Berlin, Germany | |
Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer | NCT00301548 | Breast Neoplasm... Carcinoma | perioperative c... | 18 Years - 70 Years | European Institute of Oncology | |
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study | NCT03150628 | Gastric Cancer Peritoneal Carc... HIPEC | Perioperative c... Cytoreduction HIPEC | 18 Years - | UMC Utrecht | |
Perioperative Chemotherapy in Gastric Cancer | NCT04937738 | Gastric Cancer | Docetaxel Oxaliplatin Leucovorin Fluorouracil Capecitabine Oxaliplatin | 18 Years - 80 Years | Ukrainian Society of Clinical Oncology | |
The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer | NCT01787539 | Gastric Cancer | Postoperative C... | 18 Years - | Medical University of Lublin | |
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) | NCT05872685 | Adenocarcinoma ... Adenocarcinoma ... Proficient Mism... | S1 Oxaliplatin Serplulimab Placebo | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05715931 | Adenocarcinoma ... Adenocarcinoma ... HER2-positive G... | Toripalimab Trastuzumab 5-FU, leucovori... | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University |